Small Molecule Treatment of Fatty Liver Disease and HCC
A small-molecule therapeutic approach developed for the treatment of fatty liver disease and hepatocellular carcinoma (HCC), focusing on novel compounds with potential therapeutic activity.
US 2026/0234159 A1 — Published August 13, 2026
Inventors: Adil Mardinoğlu, Mathias Uhlén, Jan Borén, Jihad Sebhaoui, Sajda Ashraf, Shazia Iqbal
Applicant: ScandiEdge Therapeutics AB
